Suchergebnisse - "Hermans, Sabine M."

Research ethics and integrity challenges in accelerated clinical trials, an interview study.

Autoren: Pallisé Perelló, Clàudia Inguaggiato, Giulia van Eck, Loïs et al.

Quelle: BMC Medical Ethics; 11/26/2025, Vol. 26 Issue 1, p1-12, 12p

Malaria recrudescence after artemether-lumefantrine treatment in travellers– a hospital-based observational study and literature review.

Autoren: Schnyder, Jenny L. Bache, Bache E. Hoogakker, Mika et al.

Quelle: Tropical Diseases, Travel Medicine & Vaccines; 7/7/2025, Vol. 11 Issue 1, p1-12, 12p

Schlagwörter: MALARIA, ANTIMALARIALS, DISEASE risk factors, REINFECTION, SCIENTIFIC observation, DIARRHEA, DISEASE relapse, TRAVELERS

Geografische Kategorien: NETHERLANDS

Post-tuberculosis treatment paradoxical reactions.

Autoren: Hermans, Sabine M. Akkerman, Onno W. Meintjes, Graeme et al.

Quelle: Infection; Oct2024, Vol. 52 Issue 5, p2083-2095, 13p

Schlagwörter: DRUG therapy for tuberculosis, THERAPEUTIC complications, ANTI-inflammatory agents, ANTIRETROVIRAL agents, HIV infections, AGE distribution, ANTITUBERCULAR agents, DISEASE relapse, DISEASE incidence, TUBERCULOSIS

Mapping the human genetic architecture of COVID-19

Autoren: null, null Niemi, Mari E. K. Karjalainen, Juha et al.

Weitere Verfasser: null, null Niemi, Mari E. K. Karjalainen, Juha et al.

Quelle: Nature
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
instname
Digibug. Repositorio Institucional de la Universidad de Granada
Universidad de Granada (UGR)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Instituto de Investigación Sanitaria La Fe (IIS La Fe)
RISalud-ANDALUCIA. Repositorio Institucional de Salud de Andalucía
Digital.CSIC. Repositorio Institucional del CSIC
Consejo Superior de Investigaciones Científicas (CSIC)
Nature (Lond.) 600 (2021): 472–+. doi:10.1038/s41586-021-03767-x
info:cnr-pdr/source/autori:Mari E. K. Niemi; Juha Karjalainen; Rachel G. Liao; Benjamin M. Neale; Mark Daly; Andrea Ganna; COVID-19 Host Genetics Initiative and the GEN-COVID Multicenter Study (including Stella, Alessandra and Biscarini, Filippo)/titolo:Mapping the human genetic architecture of COVID-19/doi:10.1038%2Fs41586-021-03767-x/rivista:Nature (Lond.)/anno:2021/pagina_da:472/pagina_a:+/intervallo_pagine:472–+/volume:600
NATURE
Nature, Vol. 600, no. ²7889, p. 472-477 (2021)
472–477
Ganna, A & Davey Smith, G 2021, 'Mapping the human genetic architecture of COVID-19', Nature. https://doi.org/10.1038/s41586-021-03767-x
Niemi, M E K, Karjalainen, J, Liao, R G, Neale, B M, Daly, M, Ganna, A, Pathak, G A, Andrews, S J, Kanai, M, Veerapen, K, Fernandez-Cadenas, I, Schulte, E C, Striano, P, Marttila, M, Minica, C, Marouli, E, Karim, M A, Wendt, F R, Savage, J, Sloofman, L, Butler-Laporte, G, Kim, H-N, Kanoni, S, Okada, Y, Byun, J, Han, Y, Uddin, M J, Smith, G D, Willer, C J, Buxbaum, J D, Karjalainen, J, Mehtonen, J, Folkersen, L, Moltke, I, Hinney, A, Wang, C, Ellinghaus, D, Brunak, S, Castro, P, Guindo-Martinez, M, Lee, J Y, Loos, R J F, Zhao, J H, Sun, Y V, Wang, B, Parker, R, Garcia, S M, Smith, O, Davis, C, COVID-19 Host Genetics Initiative, 23andMe COVID-19 Team, Norwegian SARS-CoV-2 Study Grp, Humanitas COVID-19 Task Force, Humanitas Gavazzeni COVID-19 Task, FHoGID, RegCOVID, P-PredictUs, SeroCOVID, CRiPSI, Genes & Hlth Res Team & UCLA Hlth ATLAS Data Mart Working 2021, ' Mapping the human genetic architecture of COVID-19 ', Nature, vol. 600, pp. 472-477 . https://doi.org/10.1038/s41586-021-03767-x
Baillie, J K, Wilson, J F, Bulteel, N, Hayward, C, Klaric, L, Porteous, D J, Russell, C D, Tenesa, A, Norman, L & Scott-Brown, J & Swann, O 2021, ' Mapping the human genetic architecture of COVID-19 ', Nature . https://doi.org/10.1038/s41586-021-03767-x
Nature 600, 472-477 (2021)
Initiative, COVID H G, Dark, P & Hughes, G 2021, ' Mapping the human genetic architecture of COVID-19. ', Nature, vol. 600, no. 7889, pp. 472-477 . https://doi.org/10.1038/s41586-021-03767-x
Nature, vol 600, iss 7889

Schlagwörter: Male, 45/43, Autoimmunity, FOS: Health sciences, Q1, Immunologie & maladie infectieuse, Gene, Body Mass Index, 631/208, Genetics, Genome-wide association studies, SARS-CoV-2, Viral infection, Racial Groups/genetics, Pathology, genetics, Immunology & infectious disease, Aetiology, Lung, QC, Genome-Wide Association Study, HERITABILITY, Host-Pathogen Interactions / genetics, Folkhälsovetenskap, global hälsa och socialmedicin, Inflammation/complications, COVID-19/genetics, Host-Pathogen Interactions/genetics, 3. Good health, covid-19, Oncology, Autoimmunity/genetics, Science & Technology - Other Topics, Medicine, Infection, Genotype, Critical Illness, Genetic Loci / genetics, Immunology, 631/208/205/2138, Article, COVID-19 / genetics, SDG 3 - Good Health and Well-being, Clinical Research, Biodefense, Health Sciences, Genetic architecture, Genetics, Humans, GENOME-WIDE ASSOCIATION, Biology, METAANALYSIS, 1000 Multidisciplinary, Science & Technology, Information Dissemination, SARS-CoV-2 / pathogenicity, Prevention, SARS-CoV-2/pathogenicity, Racial Groups, Pneumonia, Public Health, Global Health and Social Medicine, Mendelian inheritance, genetic architecture, COVID-19, Female, Genetic Loci, Genetic Predisposition to Disease, Geographic Mapping, Hospitalization, Host-Pathogen Interactions, Inflammation, Multifactorial Inheritance, SARS-CoV-2, Smoking, n/a, FOS: Biological sciences, 570 Life sciences, biology, Inflammation / complications, viral infection, General & internal medicine, COVID-19 / virology, Genetic variants, Medizin, Infektionsmedicin, Evolutionary biology, [SDV.GEN] Life Sciences [q-bio]/Genetics, Infectious disease (medical specialty), Genome-wide association studies, Coronavirus Disease 2019, 2.1 Biological and endogenous factors, Poly(ADP-ribose) Polymerase Inhibition in Cancer Therapy, Disease, Human health sciences, Genome Wide Association Study, pandemi, Single-nucleotide polymorphism, ddc:610, Genome-wide association, article, Public Health, Global Health, Social Medicine and Epidemiology, Metaanalysis, 10124 Institute of Molecular Life Sciences, Multidisciplinary Sciences, Infectious Diseases, Genetic Loci/genetics, [SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases, ddc:570, Technology Platforms, Médecine générale & interne, COVID-19, GWAS, genetic factors, environmental risk factors, therapy, Quantitative trait locus, Infectious Medicine, Genome-wide association study, VDP::Medisinske Fag: 700::Basale medisinske, odontologiske og veterinærmedisinske fag: 710::Medisinsk genetikk: 714, SUSCEPTIBILITY LOCI, General Science & Technology, Infectious Disease, Coronavirus Disease 2019 Research, Sciences de la santé humaine, Vaccine Related, Heritability, 692/699/255/2514, Mendelian randomization, COVID-19 Host Genetics Initiative, QH426, 631/326/596/4130, Pandemic, FOS: Clinical medicine, Human Genome, Cell Biology, Racial Groups / genetics, Coronavirus disease 2019 (COVID-19), Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi, Emerging Infectious Diseases, Good Health and Well Being, Viral infection, Autoimmunity / genetics, genome-wide association studies, Genetic association, Susceptibility loci, Clinical Characteristics

Dateibeschreibung: application/pdf; application/zip; text/xml; text; 41586_2021_Article_3767.pdf - application/pdf; Print-Electronic; 472 - +; STAMPA

Zugangs-URL: https://www.nature.com/articles/s41586-021-03767-x.pdf
https://pubmed.ncbi.nlm.nih.gov/34237774
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4476
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=18161
https://hdl.handle.net/10668/25996
http://hdl.handle.net/10261/275233
https://eprints.gla.ac.uk/261053/1/261053.pdf
https://eprints.whiterose.ac.uk/182256/1/s41586-021-03767-x.pdf
http://livrepository.liverpool.ac.uk/3146138/1/s41586-021-03767-x.pdf
https://hdl.handle.net/11588/986159
https://edoc.mdc-berlin.de/id/eprint/21782/2/21782suppl.zip
https://hdl.handle.net/11250/2982070
https://hdl.handle.net/10037/23841
https://hdl.handle.net/11250/2979981
https://hdl.handle.net/1887/3277526
https://www.nature.com/articles/s41586-021-03767-x
https://doi.org/10.1038/s41586-021-03767-x
https://hdl.handle.net/20.500.14243/439840
https://pure.amsterdamumc.nl/en/publications/9b9d281b-41f3-42fa-a9c7-956bdc4a432e
https://doi.org/10.1038/s41586-021-03767-x
http://hdl.handle.net/10044/1/92821
https://hdl.handle.net/2078.1/254580
http://hdl.handle.net/10481/72313
https://hdl.handle.net/11250/2975922
https://www.nature.com/articles/s41586-021-03767-x
https://doi.org/10.1038/s41586-021-03767-x
https://hdl.handle.net/11365/1194419
http://hdl.handle.net/21.11116/0000-000D-7243-7
http://hdl.handle.net/21.11116/0000-000B-2A7B-D
http://hdl.handle.net/21.11116/0000-0009-B290-A
http://hdl.handle.net/21.11116/0000-000C-7685-9
https://edoc.unibas.ch/95644/
https://research-information.bris.ac.uk/ws/files/284230305/covid19hgi_main_manuscript.pdf
https://hdl.handle.net/1983/29ad9d15-5550-4a5f-852e-5affc7bd1545
https://curis.ku.dk/ws/files/305692652/s41586_021_03767_x.pdf
https://hdl.handle.net/20.500.11820/b30843d0-ee8e-4512-a188-479f56bcccc7
https://www.pure.ed.ac.uk/ws/files/223461404/Mapping_the_human_genetic_architecture_of_COVID_19.pdf
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=63923
https://hdl.handle.net/11391/1507888
https://doi.org/10.1038/s41586-021-03767-x
https://hdl.handle.net/11250/2975857
https://www.nature.com/articles/s41586-021-03767-x
https://doi.org/10.1038/s41586-021-03767-x
https://hdl.handle.net/11585/893083
https://www.repository.cam.ac.uk/handle/1810/332007
https://doi.org/10.17863/cam.79455
https://doi.org/10.1038/s41586-021-03767-x
https://discovery-pp.ucl.ac.uk/id/eprint/10141419/
https://escholarship.org/content/qt54g143s1/qt54g143s1.pdf
https://escholarship.org/uc/item/54g143s1
https://eprints.soton.ac.uk/456122/
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-468462
https://www.zora.uzh.ch/id/eprint/229990/
https://doi.org/10.5167/uzh-229990
https://bura.brunel.ac.uk/handle/2438/27952
https://www.nature.com/articles/s41586-021-03767-x
https://hdl.handle.net/2318/1849926
https://doi.org/10.1038/s41586-021-03767-x

Indoleamine 2,3‐dioxygenase (IDO)‐1 and IDO‐2 activity and severe course of COVID‐19

Autoren: Guo, Lihui Roos, Eva Duitman, Jan Willem et al.

Quelle: J Pathol
also on behalf of the Amsterdam UMC COVID-19 Biobank Study Group 2021, 'Indoleamine 2,3-dioxygenase (IDO)-1 and IDO-2 activity and severe course of COVID-19', Journal of Pathology. https://doi.org/10.1002/path.5842

Schlagwörter: Adult, 0301 basic medicine, 0303 health sciences, Myocardium, 3-Hydroxyanthranilic Acid, Tryptophan, Brain, COVID-19, Apoptosis, Middle Aged, Quinolinic Acid, Severity of Illness Index, 3. Good health, 03 medical and health sciences, Humans, Indoleamine-Pyrrole 2,3,-Dioxygenase, Brief Reports, Autopsy, Prospective Studies, Lung, Kynurenine, Aged

Zugangs-URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897979
https://pubmed.ncbi.nlm.nih.gov/34859884
https://www.ncbi.nlm.nih.gov/pubmed/34859884
https://research.vumc.nl/en/publications/12f952b9-5e74-4dbb-bac1-f1bfa2a0a1a0
https://pure.amsterdamumc.nl/en/publications/ae0613f2-1091-4bb5-b739-375982ec5f17
https://doi.org/10.1002/path.5842

Repurposing of anti-malarial drugs for the treatment of tuberculosis: realistic strategy or fanciful dead end?

Autoren: Hanscheid, Thomas del Portal Luyten, Claire Ruiz Hermans, Sabine M. et al.

Quelle: Malaria Journal; 5/3/2024, Vol. 23 Issue 1, p1-9, 9p

Schlagwörter: DRUG repositioning, MYCOBACTERIUM tuberculosis, TUBERCULOSIS, ANTIMALARIALS, DRUG standards

High Rates of Recurrent Tuberculosis Disease: A Population-level Cohort Study.

Autoren: Hermans, Sabine M Zinyakatira, Nesbert Caldwell, Judy et al.

Quelle: Clinical Infectious Diseases; 6/1/2021, Vol. 72 Issue 11, p1919-1926, 8p

Schlagwörter: TUBERCULOSIS epidemiology, DRUG therapy for tuberculosis, TUBERCULOSIS risk factors, HIV infections, CONFIDENCE intervals, HEALTH status indicators, DISEASE incidence, REINFECTION, DISEASE relapse, RISK assessment, DESCRIPTIVE statistics, ANTITUBERCULAR agents, LONGITUDINAL method, PROBABILITY theory, DISEASE complications

Geografische Kategorien: SOUTH Africa

Effect of TB/HIV Integration on TB and HIV Indicators in Rural Ugandan Health Facilities.

Autoren: Burnett, Sarah M. MPH, MPA Zawedde-Muyanja, Stella MBChB, MPH Hermans, Sabine M. MD, PHD et al.

Quelle: JAIDS: Journal of Acquired Immune Deficiency Syndromes; 12/15/2018, Vol. 79 Issue 5, p605-611, 7p

Text messaging to decrease tuberculosis treatment attrition in TB-HIV coinfection in Uganda.

Autoren: Hermans, Sabine M. Elbireer, Sawsan Tibakabikoba, Harriet et al.

Quelle: Patient Preference & Adherence; Aug2017, Vol. 11, p1479-1487, 9p

Schlagwörter: TUBERCULOSIS treatment, MULTIDRUG resistance, HIV-positive persons, PATIENT compliance, ANTIRETROVIRAL agents, LOGISTIC regression analysis

The timing of tuberculosis after isoniazid preventive therapy among gold miners in South Africa: a prospective cohort study.

Autoren: Hermans, Sabine M. Grant, Alison D. Chihota, Violet et al.

Quelle: BMC Medicine; 3/23/2016, Vol. 14, p1-11, 11p, 2 Diagrams, 3 Charts, 1 Graph

Schlagwörter: TUBERCULOSIS treatment, ISONIAZID, GOLD mining, PREVENTIVE medicine, MATHEMATICAL models, MEDICAL care, TUBERCULOSIS microbiology, ANTITUBERCULAR agents, TUBERCULOSIS epidemiology, DRUG resistance in microorganisms, GOLD, LONGITUDINAL method, MYCOBACTERIUM tuberculosis, PROGNOSIS, RESEARCH funding, DISEASE incidence, DISEASE prevalence, THERAPEUTICS

Geografische Kategorien: SOUTH Africa

Inflammatory biomarkers at hospital discharge are associated with readmission and death in patients hospitalized for COVID-19.

Autoren: Slim, Marleen A. Appelman, Brent Müller, Marcella C. A. et al.

Quelle: European Journal of Clinical Microbiology & Infectious Diseases; Dec2021, Vol. 40 Issue 12, p2677-2683, 7p

Schlagwörter: NURSING home residents, COVID-19, HOSPITAL admission & discharge, LYMPHOCYTE count, SARS-CoV-2, PATIENT readmissions

Triage test for all-oral drug-resistant tuberculosis (DR-TB) regimen : a phase IV study to assess effectiveness, feasibility, acceptability and cost-effectiveness of the Xpert MTB/XDR assay for rapid triage and treatment of DR-TB

Autoren: Naidoo, Kogieleum Naidoo, Anushka Abimiku, Alash'le G et al.

Weitere Verfasser: Naidoo, Kogieleum Naidoo, Anushka Abimiku, Alash'le G et al.

Schlagwörter: Humans, Triage/methods, Mycobacterium tuberculosis/drug effects, Cost-benefit analysis, Antitubercular agents/therapeutic use, Tuberculosis, multidrug-resistant/drug therapy, Sputum/microbiology, Rifampin/therapeutic use, Feasibility studies, South Africa, Extensively drug-resistant tuberculosis/drug therapy, Ethiopia, Nigeria, Adult, Administration, oral, NDAS, SDG 3 - Good Health and Well-being, MCC

Dateibeschreibung: application/pdf

Relation: BMJ Open; 308292163; 85211208351; https://hdl.handle.net/10023/30999

Verfügbarkeit: https://hdl.handle.net/10023/30999
https://doi.org/10.1136/bmjopen-2024-084722

Unrecognised tuberculosis at antiretroviral therapy initiation is associated with lower CD4+ T cell recovery.

Alternate Title: Tuberculosis no reconocida al inicio de la terapia antirretroviral con menor recuperación de linfocitos T CD4+. (Spanish)
La tuberculose méconnue lors de l'initiation de la thérapie antirétrovirale est associée à une récupération faible des lymphocytes T CD4+. (French)

Autoren: Hermans, Sabine M. van Leth, Frank Kiragga, Agnes N. et al.

Quelle: Tropical Medicine & International Health; Dec2012, Vol. 17 Issue 12, p1527-1533, 7p

Schlagwörter: TUBERCULOSIS treatment, ANTIRETROVIRAL agents, T cells, DIAGNOSTIC errors, IMMUNE reconstitution inflammatory syndrome, OPPORTUNISTIC infections, HIV

Geografische Kategorien: UGANDA

Integration of HIV and TB Services Results in Improved TB Treatment Outcomes and Earlier Prioritized ART Initiation in a Large Urban HIV Clinic in Uganda.

Autoren: Hermans, Sabine M. Castelnuovo, Barbara Katabira, Catherine et al.

Quelle: JAIDS: Journal of Acquired Immune Deficiency Syndromes; 6/1/2012, Vol. 60 Issue 2, pe29-e35, 7p

Rifampicin for Continuation Phase Tuberculosis Treatment in Uganda: A Cost-Effectiveness Analysis.

Autoren: Manabe, Yukari C. Hermans, Sabine M. Lamorde, Mohammed et al.

Quelle: PLoS ONE; Jun2012, Vol. 7 Issue 6, p1-9, 9p

Schlagwörter: TUBERCULOSIS treatment, RIFAMPIN, COST effectiveness, MORTALITY, COMMUNICABLE diseases, CHEST diseases

Geografische Kategorien: UGANDA

Incident Tuberculosis during Antiretroviral Therapy Contributes to Suboptimal Immune Reconstitution in a Large Urban HIV Clinic in Sub-Saharan Africa.

Autoren: Hermans, Sabine M. Kiragga, Agnes N. Schaefer, Petra et al.

Quelle: PLoS ONE; 2010, Vol. 5 Issue 5, p1-8, 8p, 3 Charts, 2 Graphs

Schlagwörter: ANTIRETROVIRAL agents, TUBERCULOSIS treatment, HIV, IMMUNE reconstitution inflammatory syndrome, CD4 antigen, T cells, IMMUNOSUPPRESSION

Geografische Kategorien: UGANDA, SUB-Saharan Africa

Antiretroviral therapy and tuberculosis: does the regimen matter?

Autoren: van Leth, Frank Wit, Ferdinand WNM Hermans, Sabine M

Quelle: Expert Review of Anti-infective Therapy; Jan2014, Vol. 12 Issue 1, p5-7, 3p

Evaluation of a Nurse-Managed Wellness Centre for Healthcare Workers in Swaziland.

Autoren: Mallinson, R. Kevin Sibandze, Bongani T. Alqahtani, Naji et al.

Quelle: Africa Journal of Nursing & Midwifery; 2018, Vol. 20 Issue 2, p1-17, 17p